arrow
R

Roman Hakl

no output generated.
H指数:12
被引数:621

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis

加拉达西马布预防遗传性血管性水肿的长期综合安全性与有效性

2026-06-100
OAAI
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial

口服德库里替班坦用于按需治疗遗传性血管性水肿发作(RAPIDe-1):一项随机、双盲、安慰剂对照的2期临床试验

2026-03-190
OAAI
First report from the Czech national registry of inborn errors of immunity (2012–2025)

捷克国家免疫缺陷病登记系统(2012–2025)的第一份报告

2025-09-190
OAAI
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
2024-06-240
OAAI
Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort
2023-08-254
OAAI
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: atwo-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
LANCET
IF88.5
2023-02-0123
PRE
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
2021-07-01100
OAAI
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
2020-02-0127
OAAI